Google
×
Allogeneic stem cell transplantation from an HLA-identical sibling donor is a curative treatment option for a young patient with myelodysplastic syndrome.
Hematopoietic cell transplantation (HCT) is an effective treatment for myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML).
Missing: Haematopoietic Leukaemia
This report describes an analysis of the data from 1378 patients transplanted for MDS or secondary acute myeloid leukaemia (MDS-AML). We focused on prognostic ...
Both allogeneic and autologous stem cell transplantation have emerged as treatment options for patients with myelodysplastic syndromes. Transplantation with an ...
Jan 1, 2000 · This report describes an analysis of the data from 1378 patients transplanted for MDS or secondary acute myeloid leukaemia (MDS-AML). We focused ...
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the chronic ...
People also ask
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: a report on behalf of the Chronic ...
Missing: Leukaemia | Show results with:Leukaemia
Allogeneic hematopoietic stem cell transplantation remains the only curative option for myelodysplastic syndrome, but patients with this disease are often ...
Allogeneic stem cell transplantation is a potentially curative treatment for myelodysplastic syndromes. Transplants are clearly indicated in patients with ...
Mar 30, 2017 · A recent study in 401 patients who received HSCT for MDS or MDS/acute myeloid leukemia (AML) showed that somatic mutations in ASXL1, RUNX1, or ...